Musculoskeletal disorders (MSDs) are the number-one spend for a broad range of third-party payers, especially self-insured manufacturing companies.
These orthopedic conditions are 60% recurrent, making it difficult to determine the total cost of care (TCOC), let alone control it.
Historically, no clinically legitimate mechanism has been available to third-party payers to dramatically reduce the cost of MSDs and improve patient outcomes (e.g., through evidence-based, reliable prevention, diagnosis, and treatment strategies).
Many widely accepted approaches to MSD diagnosis and treatment lack scientific legitimacy.
Low back pain (LBP) has been the most researched medical condition in the past 30 years. It is commonly referred to as sciatica, slipped disc, lumbago, arthritis, spondylosis, strain, and sacroiliac joint pain.
90% of the population will be affected by low back pain (LBP) at least once in their lifetime.
Over 65% will experience back pain for no apparent reason.
Patients with low back pain (LBP) have a 90% chance of recurrence within three years.
95% of low back pain (LBP) can be resolved with proper clinical advice and patient compliance.
MRIs and X-rays are less reliable diagnostic and referral-support tools than Mechanical Diagnosis and Therapy.
Little scientific evidence exists in support of MRIs and X-rays in the diagnosis and treatment of low back pain (LBP) and neck pain.
No correlation has been demonstrated between low back pain and the appearance of herniated or protruding disks, degenerative bone spurs, stenosis, and/or arthritis on MRIs and X-rays.
Not all herniated or protruding disks cause pain. Among asymptomatic patients over 50 in the general population who receive MRIs or X-rays, 76% show herniated or protruding disks.
Not all bone spurs, stenoses, or arthritic conditions cause pain. Among asymptomatic patients over 60, nearly 100% show degenerative bone spurs, stenoses, and arthritic conditions.
Mechanical Diagnosis and Therapy (MDT) is the most reliable and cost-effective tool available for diagnosing MSDs and referring patients to practitioners who specialize in resolving their particular MSD.
MDT increases the effective diagnosis and treatment of musculoskeletal injury and disease without the high physical and financial costs of unnecessary MRIs, surgery and pharmaceuticals.
95% of MSD patients experience resolution of their symptoms through MDT-centric conservative care methods – most in as few as five visits.
Integrated Mechanical Care (IMC) employs “provider agnostic” MSD review teams who are trained in MDT and other diagnostic disciplines essential to accelerating patients’ speed to pain-free living and restored orthopedic function.
For patients with orthopedic conditions of mechanical origin, IMC’s MDT-trained clinicians are unsurpassed in resolving pain and improving orthopedic function.
IMC’s leadership team is so effective in designing MSD education, diagnosis, and treatment programs that the Company invites compensation models based on speed to pain-free living, orthopedic function, on-the-job performance, workforce continuity, and human-capital ROIs.